Skip Navigation
News & Information Services
 
 
 
 
 
Print This Page
Share this page: More
 

2000 Press Releases


Johns Hopkins Press Releases: 2000

DECEMBER
12/28/00 Pancreatic Cancer Vaccine Found Safe In Early Study:
Hopkins researchers say early tests of a pancreatic cancer vaccine show it is safe and successful in reaching immune system cells. A report on the findings is published in the Journal of Clinical Oncology, Vol. 19, No. 1, (January) 2001.
12/25/00 New Lab-Made Stem Cells May Be Key To Transplants:
The scientists at Johns Hopkins who, in 1998, showed that human pluripotent stem cells (hPSCs) � humans� earliest, undifferentiated "full potential" cells � could develop into all the basic types of embryonic tissues that make up human beings, have now "engineered" hPSCs to form a new type of cell that not only holds the potential to develop into different tissues but also overcomes great drawbacks that have limited the use of hPSCs for disease therapy.
12/16/00 Hopkins Arthritis Website Wins In Best-of-The-Best Competition:
A fledgling arthritis information website at Johns Hopkins has been named one of the nation�s three top nonprofit healthcare sites by a prestigious Internet company that evaluates �net enterprises for industry'.
12/15/00 Hopkins Appoints Two Senior Administrators To New Posts:
Terry Langbaum Named Chief Administrative Officer for Comprehensive Cancer Center; John Hundt, Administrator for Department of Surgery
12/11/00 Mouse Allergy Contributes To Inner-City Asthma Crisis
Parents who see mice scurrying across their floor should be worried about more than just an impending scream from their children. Mouse allergen, in the form of mouse urine or dander, is widely distributed in the inner city and may be a significant contributing factor to the childhood asthma epidemic in urban areas, according to two studies by Johns Hopkins researchers published in the December issue of the Journal of Allergy and Clinical Immunology
12/7/00 Hopkins Opens Institute Focused on Fundamental Research
The Johns Hopkins University School of Medicine today announced the formation of the Institute for Basic Biomedical Sciences (IBBS). Uniting eight departments, several hundred scientists and initiating a $125 million funding campaign, the IBBS consolidates biomedical research and teaching in the basic sciences under a single umbrella. With a jump start of $30 million from a private donor, the move marks the largest single initiative for the basic science enterprise at Hopkins in the last 50 years.
12/5/00 "Translocation" Surgery Yields Unprecedented Results
An operation developed at Johns Hopkins to halt blinding retinal damage from age-related macular degeneration (AMD) improved vision in nearly half of the first 100 patients treated, according to a recent report in the American Journal of Ophthalmology
NOVEMBER
11/30/00 First Gene Therapy To Calm Pigs' Out-of Sync Hearts
Scientists at Johns Hopkins have developed a gene therapy that, within a week, quells abnormal rhythms in pig hearts, the animal hearts most similar to human. It�s believed to be the first use of gene therapy for cardiac arrhythmias, the researchers say, and one with "a strong possibility" of transfer to human heart disease.
11/29/00 New Drug Blocks Rheumatoid Arthritis Early On, With Few Side Effects
A large nationwide study concludes that a drug called etanercept dramatically slows or even stops the progress of rheumatoid arthritis (RA) at the earliest stages of the disease, helping nearly three-quarters of those taking it. Etanercept also shows fewer side effects than the current best medicine.
11/28/00 Alfred P. Sloan Foundation Gives $3.5 Million To Hopkins Center For Civilian Biodefense Studies
The Johns Hopkins University Center for Civilian Biodefense Studies (CCBS), established two years ago to respond to the threat of bioterrorism, was awarded a $3.5 million grant by the Alfred P. Sloan Foundation.
11/27/00 One In Three Physicians Unlikely To Get Routine Medical Care
Doctor, heal thyself?  That seems the motto among a group of physicians surveyed by Johns Hopkins researchers: More than a third said they were unlikely to see a doctor on a regular basis
11/23/00 Henry Brem Named New Director of Hopkins Neurosurgery
Henry Brem, M.D., a nationally acclaimed neurosurgeon, is the new director of neurosurgery at Johns Hopkins. Brem succeeds neurosurgeon Donlin Long, M.D., the department�s chairman for 27 years.
11/15/00 Blood Components Indicate Risk of Rejecting A Transplanted Heart
Two tiny substances in the blood might alert physicians to which heart transplant patients are likely to experience some form of organ rejection, a Johns Hopkins study indicates.
11/15/00 Women Less Likely to Get "Aggressive" Treatment for Vessel Disease
Looking for a clue to the continuing cycle of hospitalizations among men and women with congestive heart failure (CHF) cased by coronary artery disease (CAD), Johns Hopkins researchers have observed that women with ischemic CHF (caused by lack of oxygen to the heart muscle) have a four-fold increased risk of being readmitted to the hospital due to factors such as repeated angioplasties, rhythm disturbances and ischemic events.
11/13/00 Antibiotics, Yogurt Seen As Potential Treatment for Common Liver Disorder
If mouse studies hold true for humans, a daily cup of yogurt or dose of antibiotics may become the first effective treatments for a common and sometimes fatal obesity-related liver disorder, Hopkins scientists report.
11/10/00 Korean Americans At Risk For High Blood Pressure
A Johns Hopkins study of Korean Americans found that they have hypertension at rates much higher than other Americans or their counterparts in Korea. Stress, diet and lifestyle changes that occur as a result of immigration can contribute to the high prevalence of cardiovascular disease and stroke, concludes Miyong Kim, PhD, RN, a nurse researcher and assistant professor at The Johns Hopkins University School of Nursing.
11/10/00 Hopkins Researcher Finds Bone Disease and Growth Defect May Have Common Genetic Basis
An examination of two rare, very different and hereditary bone disorders has revealed clues about the common genetic switches controlling normal bone development, according to new research guided by Johns Hopkins Children�s Center endocrinologist Michael Levine, M.D.
11/8/00 Hopkins Researchers Develop Method to Predict Response to Chemotherapy
Researchers at the Johns Hopkins Oncology Center uncovered a genetic alteration that appears to predict how individuals with an aggressive type of brain cancer will respond to chemotherapy.
11/6/00 Hopkins Scientists Show Enzyme Is Key to Hallmark of Alzheimer's
Scientists at Johns Hopkins have demonstrated that a specific enzyme in the brain is essential for nerve cells to form a hallmark of Alzheimer's disease (AD), the so-called amyloid plaques that collect and surround brain cells. While aging brains of apparently healthy people contain scattered amyloid plaques, the brains of AD patients are littered with them.
11/6/00 More Vigilance, Faster Action, Reduce Hospital Time and Costs for Childhood Asthma Attacks
A Johns Hopkins study has found that children hospitalized with a severe asthma attack can be safely weaned from powerful asthma drugs very quickly after their symptoms begin to ease, getting them home faster and potentially saving the nation's health care system millions of dollars by decreasing the amount of medication children need.
11/5/00 Stem Cells Graft In Spinal Cord, Restore Movement In Paralyzed Mice
Scientists at Johns Hopkins report they�ve restored movement to newly paralyzed rodents by injecting stem cells into the animals� spinal fluid. Results of their study were presented at the annual meeting of The Society for Neuroscience in New Orleans.
11/4/00 Depression Film Wins FREDDIE Award
Day For Night: Recognizing Teenage Depression, a powerful look into depression as told through teenage testimonies, has won a FREDDIE Award for outstanding coping film, to be presented at the 26th Annual International Health and Medical Media Awards � Time Inc.
11/3/00 Joseph Cofrancesco Nominated For 2000 AAMC Humanism in Medicine Award
Joseph Cofrancesco Jr., M.D., M.P.H., assistant professor in the Department of Medicine at Johns Hopkins, was one of 47 physicians nationwide nominated for the Association of American Medical Colleges (AAMC) Humanism in Medicine Award for 2000. Sponsored by the AAMC and the Pfizer Medical Humanities Initiative, the award annually honors medical school faculty physicians who embody the finest qualities of a healer and teacher.
11/1/00 African Americans Fare Less Well Than Whites After Stroke Prevention Surgery
African Americans who undergo the most frequently performed blood vessel operation, carotid endarterectomy (CEA), have worse outcomes than whites, according to a new study by Johns Hopkins researchers. The study, reported in the November issue of Annals of Surgery, blames the discrepancy, in part, on the fact that African Americans tend to be operated on by less experienced surgeons than whites.
11/1/00 Two New Meds Help Heroin Addicts, Study Shows; Take Users Off Daily Dose Treadmill
Scientists at Johns Hopkins report that some people who suffer with repeated sinus infections may be predisposed to them in part because they carry the same genetic mutation responsible for cystic fibrosis(CF).
OCTOBER
10/31/00 Hopkins Part of New Program to Detect Early Heart Disease
Members of the media are invited to meet the Johns Hopkins investigators leading Baltimore�s efforts to detect heart disease early in different ethnic groups as part of a new national study.
10/26/00 Hopkins Names Orthopedics Chief
Concluding a nationwide search, Johns Hopkins University School of Medicine officials have named Frank J. Frassica, M.D., chairman of the Department of Orthopaedic Surgery, citing his "outstanding credentials as an educator, his administrative performance as interim vice chairman of the department, and his international reputation as a surgeon and leader in the field."
10/23/00 Hopkins Hospital Named 2000 Quality Leader
The National Research Corporation (NRC) has named The Johns Hopkins Hospital one of 121 hospitals nationwide to earn its Quality Leader Award.
10/18/00 Second NATIONAL SYMPOSIUM ON BIOTERRORISM, NOV. 28-29, Washington, D.C.
For the second consecutive year, political leaders, public health and medical professionals, research scientists, law enforcement, and national security experts will convene to explore how best to confront the threat of a bioterrorist attack on civilians in the United States.
10/20/00 Election to the National Academy of Sciences' Institute of Medicine Fibrosis Patients
The dean of the Johns Hopkins School of Medicine and five other faculty have joined the ranks of the National Academy of Sciences' Institute of Medicine, a prestigious body that brings together national scholars and leaders in health and medicine, social and behavioral sciences, law, administration and economics to develop recommendations on a broad range of health policy issues.
10/17/00 New Technique Will Improve Delivery of Drugs and Gene Therapy for Cystic Fibrosis Patients
Johns Hopkins researchers have successfully targeted aerosol particles to smaller, harder to reach airways in the lungs of people with cystic fibrosis (CF). The work, reported in the October issue of Chest, could lead to improved drug treatments for CF patients (30,000 in the United States) and in the future, to a means of optimizing the delivery of gene therapy.
10/16/00 Hopkins Gets $2.7 Million NCI Grant For Breast Cancer Research
Researchers at the Johns Hopkins Oncology Center have been awarded a five-year multimillion-dollar grant from the National Cancer Institute (NCI) for breast cancer research. Known as SPORE (Specialized Programs of Research Excellence) the prestigious grant will provide $2.7 million during the first year of funding for breast cancer risk assessment, diagnosis, treatment and prevention.
10/13/00 Hopkins Wins $14 Million NIH Grant for Genetic Cardiopulmonary Disease Research
The Johns Hopkins Division of Pulmonary and Critical Care Medicine has received a $14 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to identify genes involved in 10 heart and lung diseases, with the goal of enhancing their diagnosis and treatment. The grant will be distributed over the next four years, and the division will have a chance to renew for an additional four-year period.
10/12/00 Hopkins Scientists Shed Light on How the Brain "Thinks' 
Bioengineers at the Johns Hopkins Medical Institutions, taking Plato�s concept of reality and illusion into the world of robots, have uncovered some of the algorithms of learning, the �primitives� the brain uses to comprehend the world. In particular, they have described the mathematical shapes used to control movements of the arms.  The primitives demonstrate why certain tasks are hard for us to learn, and that there may be fundamental limitations to what is learnable by the human brain. 
10/11/00 Inhaled Steroids Prove Safe and More Effective for Treating Mild Asthma Than Non-Steroidal Therapies
Children who use inhaled steroids to control their asthma do not have to worry about stunting their growth, according to a study in the New England Journal of Medicine. In addition, steroidal therapy provides better treatment for asthma than non-steroidal therapy in terms of significantly reducing the number of hospitalizations and urgent care visits, as well as the need for additional asthma medications.
10/10/00 Hopkins Researchers Uncover Sinus Infection-CF Link
Scientists at Johns Hopkins report that some people who suffer with repeated sinus infections may be predisposed to them in part because they carry the same genetic mutation responsible for cystic fibrosis(CF).
10/10/00 Hopkins Launches Project To License Consumer Health Content
Johns Hopkins University and Health System today announced the launch of HopkinsHealth, which will license Hopkins-branded consumer health information to the online community.
10/5/00 "Robotic" Surgeries Being Performed at Hopkins
Hopkins is one of only a handful of medical centers (and the only one in this region) to perform laparoscopic "robotic" surgeries for general abdominal procedures such as gallbladder removal and treatment of gastroesophageal reflux, or heartburn.
10/5/00 Hopkins Gets $7.8 Million NIH Grant For Alternative Medicine Center
 Does prayer help heal African-American women with breast cancer? To answer such questions, Johns Hopkins Medicine has been awarded a five-year, $7.8 million grant from the National Institutes of Health (NIH) to establish a research center to study complementary and alternative medicine in the treatment of cancer. 
SEPTEMBER
9/29/00 Hopkins Merges Two Groups To Form Johns Hopkins Community Physicians
In a move to reaffirm its commitment to primary care while streamlining operations, Johns Hopkins Medicine created Johns Hopkins Community Physicians, a merger of the primary care practice of Johns Hopkins Bayview Physicians and the Johns Hopkins Medical Services Corporation (MSC).
9/28/00 Scientists Spot Way Around Cystic Fibrosis Cells' Poor Performance, Way To Improve Drug Testing
Exploiting what appears to be a newly found regulator of cystic fibrosis chemistry, scientists at Johns Hopkins report they have been able to experimentally improve the function of the cell molecule most affected by this common inherited disorder.
9/26/00 Johns Hopkins Surgeon Develops New Technique to Improve Breast Cancer Detection and Surgery
A Johns Hopkins breast surgeon has developed an important new way to find breast cancers that would otherwise go undetected by existing techniques.
9/21/00 Wilmer Eye Institute Named Top Program by Ophthalmology Times
For the fifth year in a row, the Wilmer Eye Institute at Johns Hopkins has been named the best overall ophthalmology program in the country by Ophthalmology Times magazine. 
9/20/00 Hopkins New Cell and Gene Therapy Facility Promises New Therapies for Cancer, Diabetes and Other Diseases
A new research laboratory dedicated to the genetics and cell biology of cancer and other diseases opens this week on the Johns Hopkins medical campus in East Baltimore. A joint project of the Johns Hopkins School of Medicine and the Oncology Center, the Cell and Gene Therapy Laboratory is one of only a dozen such facilities in the United States designed to produce cellular and gene therapy drugs and vaccines for clinical trials in cancer, diabetes, and other diseases.
9/19/00 Annual PSA Tests For Men May Not Be Best, Says Joint Study
The standard, widely-used approach to screen men for prostate cancer -- annual PSA tests after age 50 --� may be less efficient and cost-effective than one that tests men earlier and less frequently, according to a study in the Journal of the American Medical Association.
9/10/00 Easy-to-use Clinical Tests Help Determine Older Women's Risk for Early Physical Disability
A series of simple tests can help care providers predict whether older women will develop physical disabilities in the near future, Johns Hopkins researchers have found.
9/6/00 Ritalin Use In Maryland Schools Lowest For Minorities, Highest For Special Education
Nearly three percent of Maryland public school students receive medication, most commonly the methylphenidate trademarked Ritalin, during school hours for treatment of attention deficit hyperactivity disorder (ADHD), according to a Maryland State Department of Education-supervised survey of school nurses.
9/5/00 Study Says Youthful Knee Knocks Raise Arthritis Risk, Suggests Earlier Prevention
A study following more than a thousand medical school graduates for nearly 40 years has shown that young adults who've injured their knees have a substantially increased risk of developing arthritis as older adults.
AUGUST
8/30/00 Molecule Causing One-Eyed Sheep Also Quells Cancer Pathway
Scientists at Johns Hopkins and the Howard Hughes Medical Institute have shown, in mouse cells, that they can shut down a cell pathway that's key to several human cancers and can apparently reverse the shift into unrestrained cell division typical of malignancy. The cancers include basal cell carcinoma, the most common type of skin cancer.
8/29/00 Researchers Zero In On First Drug That May Be Helpful In Treating Common Liver Disease
Studies in mice show that a drug used to treat diabetes, called metformin, may be helpful in combating a common and potentially fatal liver disorder. The discovery, reported in the September issue of Nature Medicine, may lead to the development of the first drug to treat people who suffer from the condition known as fatty liver, the researchers say.
8/29/00 Hopkins Reports New Chemoprevention Strategy For Colon Cancer
"A team of scientists at Johns Hopkins, Howard Hughes Medical Institute, and Wyeth-Ayerst Research, has been able to prevent colon tumors in mice genetically susceptible to the disease, by using a two-drug combination. One of the drugs is an aspirin-like compound, sulindac, and the other is a newly developed chemical known as EKB-569, which inhibits a tumor-specific growth factor. The findings, reported in the September 1, 2000 issue of Nature Medicine, have potential for treating people with a similar predisposition.
8/22/00 Kwang Sik Kim, M.D., Named Director, Hopkins Pediatric Infectious Diseases
Kwang Sik Kim, M.D., an expert on meningitis and other nervous system infections, is the new director of infectious diseases at the Johns Hopkins Children's Center
8/22/00 David Bricker Joins Children's Center Public Affairs Team
David Bricker has been hired as a senior media relations representative for the Johns Hopkins Children's Center Office of Communications and Public Affairs, to report on faculty research and work with reporters to develop stories on basic science and clinical research advances at the Children's Center.
8/21/00 Balanced Diet Lowers Homocysteine, Reducing Risk of Heart Disease
Researchers at Johns Hopkins have found yet another reason to eat a well-balanced diet low in fats and rich in fruits and vegetables: It lowers blood levels of homocysteine, thereby reducing the risk of heart disease.
8/15/00 Study Finds Cochlear Implants Cost-Effective In Children
Researchers at Johns Hopkins report that cochlear implants, electronic devices surgically implanted behind the ear to bring sound to profoundly deaf people, not only improve children's quality of life, but also are highly cost-effective, with an expected lifetime savings of $53,198. The study, published in the Aug. 16 issue of the Journal of the American Medical Association (JAMA), is the first to evaluate the cost of quality-of-life improvements in pediatric cochlear implant patients using U.S. cost data, the authors say.
8/14/00 Caffeine In Colas: "The Real Thing" Isn't The Taste
The majority of people who drink colas can't tell whether a soda contains caffeine or not, according to a new Johns Hopkins study. "This stands in sharp contrast to the claim some soft drink manufacturers make that they add caffeine purely for taste," says psychopharmacologist Roland Griffiths, Ph.D., who directed the research.
8/9/00 Children's Center Researchers Question Role of Androgens In Sex Drive and Function
Researchers from the Johns Hopkins Children's Center have determined that over the course of their lives, women who possess the same sex chromosomes as men -- by virtue of a genetic mutation that leaves them completely insensitive to male sex hormones called androgens -- can still lead active, normal sex lives. The study, which appears in the August 2000 issue of The Journal of Clinical Endocrinology & Metabolism, suggests that androgens, long thought to enable women to experience orgasm and heighten their sex drive, may not be essential after all.
8/7/00 Johns Hopkins Unveils Newest Weapon In Fight Against Asthma: The BreathMobile
Asthma is the single most common reason for visiting the Pediatric Emergency Department at Johns Hopkins Children's Center, and a leading cause of school absenteeism. Now, the Children's Center is bringing a mobile asthma clinic to East Baltimore schools to assess children's risk for the disease, and provide treatment, education and prevention strategies
8/4/00 Hopkins Research May Bring "Sigh" of Relief To Asthmatics
For several years, researchers have known that deep breaths benefit the lungs of healthy individuals by pushing open narrowed airways. Now, Johns Hopkins researchers have discovered that deep breaths also provide protection by preventing airways from closing in the first place. The findings may lead to a real sigh of relief and new treatments for asthmatics.
JULY
7/31/00 Insulin, Viagra, Point To Relief for Diabetics' Gut Feelings
One of the quiet miseries of long-term diabetes is a condition called gastroparesis --a failure of the stomach to empty after a meal because the valve-like pyloric muscle won't relax. Gastroparesis affects nearly 75 percent of people who've had diabetes more than five years, causing bloating, pain, loss of appetite and, on occasion, vomiting and dehydration.
7/25/00 Minimally Invasive Procedure Offers Long-term Pain Relief for Patients with Pancreatitis
Many more patients with chronic pancreatitis can safely turn to a minimally invasive operation for long-term pain relief, according to a new study by Johns Hopkins physicians. Endoscopic therapy is an effective alternative to more invasive surgery or drugs, says Anthony N. Kalloo, M.D., director of gastrointestinal endoscopy at Hopkins and lead author of the study that appears in the July issue of Gastrointestinal Endoscopy.
7/14/00 Heart Failure Patients with Worst Heart Function Are Good Candidates for Pacemakers
The pacemaker has taken on an increasingly important role in recent years. Originally used to fix electrical abnormalities in people with irregular heart rhythms, it is now in favor for heart failure patients as a way to "resynchronize" a weak and struggling heart.
7/12/00 Johns Hopkins Medicine Appoints New Board Member
Pamela P. Flaherty, senior vice president of Citigroup, has been appointed to the Johns Hopkins Medicine Board of Trustees, effective July 1, 2000.
7/11/00 Current HIV Treatment Guidelines May Result in More Men than Women Being Eligible for Treatment
Helping to clarify a long-standing issue, a study by researchers at Johns Hopkins shows that women carry lower levels of HIV in their blood than men, especially during early phases of the infection, but have the same risk as men of developing AIDS. One consequence of the findings: viral load thresholds used by doctors to begin anti-retroviral drug therapy could result in more men getting offered treatment than women, particularly early in the course of infection.
7/10/00 Hopkins Researchers Identify Potential New Cancer Gene
A Johns Hopkins research team has discovered a new family of genes that contributes to the process of malignancy, shedding new light on the abnormalities that give rise to the aggressive childhood cancer, Burkitt's lymphoma --as well as lymphoma, leukemia, prostate, ovarian, lung and breast cancer.
7/7/00 An Even Decade: JHH Tops USN&WR "Honor Roll" 10 Years In A Row
For the 10th consecutive year, U.S. News & World Report's annual ranking of American hospitals has placed The Johns Hopkins Hospital at the top of the list. "The Johns Hopkins Hospital, with exceptional performance across 16 of 17 specialty rankings...leads the U.S. News Honor Roll of hospitals that do many things exceptionally well," the magazine said.
7/7/00 Johns Hopkins Establishes Urban Health Institute To Improve Health Of East Baltimore
After more than a year of working closely with the East Baltimore community to identify their health concerns, Johns Hopkins has committed $4.5 million over a period of five years to establish an Urban Health Institute to tackle the vexing health problems that plague that community. The Institute brings together a wide range of Hopkins' health experts, community leaders, business leaders, clergy, and state and local city agencies to forge a partnership that will first identify the most pressing health issues and then develop the best methods, including research, education and community outreach, to address these problems.
7/1/00 Universal Newborn Hearing Screening in Maryland
The tests are simple and inexpensive and can produce life-changing results, yet more than half of the 50 states do not require universal hearing screenings for newborn infants by law. On July 1, 2000, Maryland puts into effect such a law requiring hospitals to perform tests on all newborns to identify hearing loss prior to their discharge from the hospital.
JUNE
6/29/00 Compound That Switches Off Appetite In Mice Discovered By Hopkins Scientists
Johns Hopkins scientists have produced a compound capable of rapidly turning off appetite in mice and causing weight loss similar in many ways to that achieved by fasting. When injected, the substance, which is apparently non-toxic to the mice, wipes out the animals' interest in food within 20 minutes. The effect of the chemical called C75 wears off a few days after injections stop, the researchers say, and the mice resume normal feeding.
6/29/00 Compound That Switches Off Appetite In Mice Discovered By Hopkins Scientists
Johns Hopkins scientists have produced a compound capable of rapidly turning off appetite in mice and causing weight loss similar in many ways to that achieved by fasting. When injected, the substance, which is apparently non-toxic to the mice, wipes out the animals' interest in food within 20 minutes. The effect of the chemical called C75 wears off a few days after injections stop, the researchers say, and the mice resume normal feeding.
6/29/00 Helping To Better Understand the Development and Maturation of the Auditory Pathway
Scientists at Johns Hopkins have discovered the function of a group of nerve fibers that originates in the brain stem and fires off signals even before newborn rats can hear. The signals may be a process for wiring the ears and brain for hearing, much like laying down circuits on a computer chip.
6/28/00 Aravinda Chakravarti Named Head of Genetic Medicine Institute
Aravinda Chakravarti, Ph.D., an expert in computational biology and a geneticist renowned for his studies of predisposing genetic factors in such common and complex human diseases as diabetes, heart disease and mental illness, has been named director of The Johns Hopkins School of Medicine's new McKusick-Nathans Institute for Genetic Medicine.<.
6/28/00 Frequent Pressure Shifts Increase Risk of Blindness in Glaucoma Patients
The more eye pressure fluctuates during the day, the higher the risk that a glaucoma patient will lose vision, according to a study by researchers at Johns Hopkins and two other academic medical centers.
6/23/00 Human Genome Project
Press reports suggest that after several years' competition, the public and private laboratories vying to create a working draft of the human genetic instructions � the genome � will jointly announce their progress on Monday.
6/22/00 Amino Acid Supplements Improve Dialysis Patients' Health
Amino acid supplements may provide a cost-effective and safe method for improving the nutritional intake of some dialysis patients who are unable to meet their daily protein requirements, a Johns Hopkins study shows.
6/21/00 Fireworks Safety
Fireworks are among the most popular and exciting ways to celebrate Independence Day and also one of the most dangerous. Approximately 12,000 Americans are admitted to emergency rooms every year for fireworks-related injuries, either from misuse or malfunction, according to the United States Eye Injury Registry (USEIR).
6/20/00 National HIV Testing Day: Free Tests June 27
The U.S. Centers for Disease Control and Prevention (CDC) says 200,000 Americans are living with undiagnosed HIV/AIDS at a time when early diagnosis and treatment can keep people healthy and active for many years.
6/19/00 AEGON Awards Hopkins $2 Million Grant for Breast and Prostate Cancer Research
"Insurance conglomerate AEGON USA Charitable Foundation and AEGON N.V. has committed $2 million to Johns Hopkins for prostate and breast cancer research. The Johns Hopkins Oncology Center will split the funds with the Free University Oncology Research Institute in Amsterdam, the Netherlands, for a collaborative research project with Hopkins. This is the largest gift AEGON has ever made.
6/16/00 More Tolerable Treatment for Severe, Obstructive Sleep Apnea Around the Bend
While the most effective treatment for severe, obstructive sleep apnea is a tracheotomy, many people decline to have the operation because they loathe the idea of having a quarter sized opening in their neck. Now, a study in the June issue of American Journal of Respiratory and Critical Care Medicine, proves that a tiny 2 millimeter opening can work as well when combined with a new technology to monitor the flow of air. The finding may lead to new treatments in the future.
6/7/00 Bellamy, Saul New Johns Hopkins Medicine Trustees
Johns Hopkins Medicine has named Sherry Bellamy, president and CEO of Bell Atlantic-Maryland, Inc., and Francis Saul, a Maryland banker, to its Board of Trustees.
6/7/00 Hopkins to Break Ground For New Research Building
Groundbreaking occurs on June 12 for construction of a 10-story, $140 million research building at Johns Hopkins' East Baltimore campus that's a concrete-and-brick metaphor for today's biomedical science.
6/7/00 Hopkins Hosts 400 Transplant Patients at Conference June 10
U.S. Rep. Elijah E. Cummings (D-Md.) will give the keynote address at a day-long educational seminar Saturday, June 10, sponsored by the Johns Hopkins Comprehensive Transplant Center, at Marriott's Hunt Valley Inn. More than 400 transplant patients and their families from across the country are expected to attend.
6/6/00 Nurses, Alert Janitors Boost Seniors' Mental Health
In the case of older adults with psychiatric problems, a four-year Johns Hopkins study has shown that a program combining observations by janitors, building managers and others who frequently see elderly people and the skills of a highly accessible psychiatric nurse can significantly increase seniors' mental health and stability.
6/6/00 80 People Offer Kidneys To Strangers Following Publicized Hopkins Transplant
Eighty people so far have called Johns Hopkins to inquire about donating a kidney to a stranger in need since a widely publicized transplant in September, when an Indiana woman gave a kidney to a Maryland teen she met just days before the operation.
6/1/00 Hopkins' Emergency Medicine Celebrates 25th Anniversary June 1-4
The Department of Emergency Medicine at Johns Hopkins will celebrate its 25th anniversary June 1-4 with a high-profile seminar on emergency response to bioterrorism and a black-tie gala. Baltimore philanthropist and former Hopkins Hospital Board Chairman Harvey M. "Bud" Meyerhoff will serve as master of ceremonies for the gala, to be held at the Hyatt Regency Baltimore on June 3.
MAY
5/31/00 Hopkins Appoints New Head of Cell Biology and Anatomy
Peter N. Devreotes, Ph.D., a world authority on the chemical signaling that takes place between cells, is the new head of the Department of Cell Biology and Anatomy at the Johns Hopkins School of Medicine, effective June 1, 2000.
5/30/00 Hopkins Researchers Successfully Using Behavioral Techniques, Set up a Non-profit Business to Employ and Treat Drug Addicts
Johns Hopkins researchers, successfully using behavioral techniques to keep drug addicts abstinent, have formed a non-profit data processing company to employ the addicts and provide them with monetary incentives to stay off drugs.
5/23/00 Hopkins Chief Surgeon Named President of the American Surgical Association
John L. Cameron, M.D., surgeon-in-chief of The Johns Hopkins Hospital and professor and director of the Department of Surgery at the Johns Hopkins University School of Medicine, was elected president of the American Surgical Association during the organization's recent annual meeting in Philadelphia.
5/23/00 Tip Sheet- the 36th Annual Meeting of The American Society of Clinical Oncology (ASCO)
News tips are based on abstracts or posters being presented at the annual meeting of the American Society of Clinical Oncology (ASCO).
5/22/00 Lutein Supplements May Improve Vision
A substance found in dark green leafy vegetables and egg yolks may improve vision in people with retinitis pigmentosa (RP) and other degenerative eye conditions, according to a study published by a Johns Hopkins researcher, whose subjects were recruited from the Internet and tested via e-mail.
5/22/00 "Scarlet E" Still Taints Media, Still Distorts Epilepsy
The age-old stigma against people with epilepsy is alive and well in the print media. That's the consensus of neurologists at Johns Hopkins and the University of Maryland who screened several hundred recent popular press articles on epilepsy/seizures for misinformation or outright errors. Their study appears in this month's edition of the journal Neurology in an article titled The Scarlet E.
5/19/00 Hopkins Sponsors Cancer Survivors Conference and Celebration
The first annual Johns Hopkins Comprehensive Cancer Center/Cancer Survivorship Conference and Celebration is scheduled for Saturday, June 3rd.
5/18/00 Researchers Present New Theory for Allergic Diseases
Johns Hopkins researchers have discovered, to their surprise, that a nervous system protein may have a significant role in asthma, hay fever and other allergies. According to the new research reported in the May issue of the American Journal of Respiratory and Critical Care Medicine, the protein, nerve growth factor (NGF), may be responsible for making allergy sufferers more sensitive to irritants such as tobacco smoke.
5/15/00 Clot-Busting Drugs Don't Benefit Older Heart Attack Patients
Contrary to general belief among doctors, clot-busting drugs � the main emergency treatment for heart attack victims � fail to benefit patients more than 75 years old and may actually increase their risk of death, according to results of a Johns Hopkins-led study.
5/14/00 Johns Hopkins Pediatric Geneticist Receives National Award For Research
For landmark discoveries of how human cells respond to hypoxia, or a state of oxygen deprivation, Gregg L. Semenza, M.D., Ph.D., of the Johns Hopkins Children's Center and Johns Hopkins Institute of Genetic Medicine today receives the annual E. Mead Johnson Award, for pre-eminent contributions to American pediatrics. Semenza's work sheds light on basic molecular processes which, when they go awry, can lead to some of the most common causes of death in the United States, including heart disease and cancer.
5/15/00 Vaccines Protect Kids with Artificially Suppressed Immune Systems
To prevent organ rejection, children who receive kidney transplants must take medications to suppress the body's immune system. To learn whether common childhood vaccinations � which play an integral role in immunity � are effective when given to children with kidney transplants, pediatric nephrologist Alicia Neu, M.D., of the Johns Hopkins Children's Center measured antibody levels in 19 pediatric kidney patients after pneumococcal vaccine
5/15/00 Children With Educated Parents Are More Likely To Receive Transplants
Studies have shown that socioeconomic background plays a role in whether and when children with kidney failure receive a transplant. To determine whether parental education � one aspect of socioeconomic status � influences physicians' recommendations for transplant, researchers at Johns Hopkins Children's Center presented 600 adult and pediatric nephrologists with 10 hypothetical case studies. The cases reflected a random combination of patient characteristics including age, gender, race, cause of end-stage renal disease (ESRD), family structure, parent education, and patient compliance with prescribed treatment and medication plans.
5/15/00 Clot-Busting Drugs Don't Benefit Older Heart Attack Patients
Contrary to general belief among doctors, clot-busting drugs � the main emergency treatment for heart attack victims � fail to benefit patients more than 75 years old and may actually increase their risk of death, according to results of a Johns Hopkins-led study.
5/14/00 Johns Hopkins Pediatric Geneticist Receives National Award For Research
For landmark discoveries of how human cells respond to hypoxia, or a state of oxygen deprivation, Gregg L. Semenza, M.D., Ph.D., of the Johns Hopkins Children's Center and Johns Hopkins Institute of Genetic Medicine today receives the annual E. Mead Johnson Award, for pre-eminent contributions to American pediatrics. Semenza's work sheds light on basic molecular processes which, when they go awry, can lead to some of the most common causes of death in the United States, including heart disease and cancer.
5/14/00 "Real World" Offers Data To Enhance Safety of Ambulance Transport of Children
A four-month study of more than 200 ambulance arrivals at an urban medical center suggests that the potential for injury to children and other occupants should the vehicle crash during transport is "alarmingly prevalent," a Johns Hopkins research team says
5/12/00 Hopkins Research Shows Nature, Not Nurture, Determines Gender
Two Johns Hopkins Children's Center studies confirm that prenatal exposure to normal male hormones alone dictates male gender identity in normal XY male babies, even if they are born without a penis. The results seriously question the current practice of sex-reassigning some of these infants as females, performing castrations or other surgery to align them cosmetically and hormonally with a female role.
5/12/00 Quicker Asthma Diagnoses May Lower Hospital Admission Rates for Elderly
Doctors can lower hospital admission rates of older asthma patients if they diagnose asthma problems earlier and control other illnesses, according to a new study by Johns Hopkins researchers. The study was designed to find out why older adults are hospitalized for asthma at much higher rates than younger adults.
5/10/00 Doctors and Patients, Digestive Diseases Baffling You? Turn to New Interactive Digestive Disease Website
Patients and physicians with questions about digestive diseases now can turn to a newly launched website for answers.
5/7/00 Common Lung Exam Often Causes Unnecessary Pain: More Pain Control Needed
A common, invasive procedure used to test for lung disease may be causing patients unnecessary pain, according to a new study. While most physicians always use topical anesthetic before flexible bronchoscopy (FOB), many believe that other pain killers aren't needed. Now, Johns Hopkins researchers have shown that, even when sedatives and analgesics are routinely used, some patients suffer pain.
5/5/00 Nursing Makes News During National Nurses Week May 6-12
National Nurses Week begins May 6 and ends on May 12, Florence Nightingale's birthday. The role of nursing since Nightingale's influence has changed broadly in the age of managed care and health care reform. Yet, with all the changes taking place around them, nurses continue their role as patients' strongest advocates.
5/3/00 Hopkins Scientists Link Human Papillomavirus (HPV) To Head and Neck Cancer
Researchers at the Johns Hopkins School of Medicine and School of Hygiene and Public Health have found the sexually transmitted human papillomavirus (HPV) to be a likely cause of certain cancers of the head and neck and also an indicator of improved survival. Their findings are reported in the May 3, 2000, issue of the Journal of the National Cancer Institute.
5/1/00 Hopkins Researcher Wins $250,000 Award From General Motors
Bert Vogelstein, M.D., Clayton Professor of Oncology at Johns Hopkins and Investigator, Howard Hughes Medical Institute will receive the General Motors Cancer Research Foundation Charles S. Mott Prize which honors the most outstanding recent contributions to the discovery of the causes or prevention of cancer.
APRIL
4/27/00 Cat Allergy Sufferers Find Relief in Asthma Drug
Scientists at Johns Hopkins have found that individuals who have the misfortune to be allergic to cats can find welcome relief and protection from symptoms in one of a new class of drugs already known to help other asthmatics.
4/26/00 Wilmer Eye Institute Celebrates 75th Anniversary April 28-29
The Wilmer Eye Institute at Johns Hopkins will celebrate its 75th anniversary April 28 and 29 with a two-day international scientific and clinical conference and black tie gala. Former ABC News' "20/20" anchorman Hugh Downs will serve as master of ceremonies, and former astronaut and U.S. Sen. John Glenn will speak. Both are former patients and members of the Wilmer Advisory Council.
4/21/00 Study Shows Obsessive-Compulsive Disorder Runs in Families
Researchers have laid to rest the myth that another mental disorder stems from �bad parenting.� A new study from Johns Hopkins has shown that obsessive-compulsive disorder (OCD), like schizophrenia and bipolar disorder, tends to run in families and has a strong genetic basis.
4/6/00Researchers Identify Drug Target To Treat Sleeping Sickness
Johns Hopkins researchers have discovered a new metabolic pathway in a parasite that could lead to drugs for treating so-called African sleeping sickness. The discovery, reported in the April 7 issue of Science, provides hope for the estimated 500,000 people who are fatally infected with the African trypanosome.
4/6/00 Hopkins Offers New Transplant Technique
A new procedure offered by the Johns Hopkins Comprehensive Transplant Center enables a kidney transplant between any two people, regardless of blood type.
4/5/00 Hopkins Opens Cardiac Rehabilitation Program at Maryland Athletic Club
Johns Hopkins Medicine has opened a clinical exercise center featuring one of the first uses of computer-driven fitness equipment for patients with heart problems. The program, called Heart Health, is based at the Maryland Athletic Club in Timonium.
4/3/00 New Vaccine Technique Offers Hope For Asthma and Allergy Sufferers
For years, efforts to develop improved vaccines for asthma and allergies have been thwarted because the vaccines themselves often cause the very symptoms a person is trying to avoid. Research efforts have been aimed at attempting to improve efficacy, increase safety, decrease treatment time and improve compliance. Now, at a recent conference, researchers at Johns Hopkins, the University of California at San Diego, and Dynavax Technologies Corporation announce that they have developed a method of modifying an allergen, such as ragweed, to create a vaccine that may solve many of these concerns.
4/3/00 Hopkins, Technion-Israel Institute of Technology Establish Biomedical Sciences and Biomedical Engineering Program
The Johns Hopkins University and the Technion-Israel Institute of Technology in Haifa, Israel, have signed an agreement to establish a joint research and educational program in biomedical sciences and biomedical engineering. A major objective of the program is to enhance collaborative research between the institutions and speed the commercialization of new products.
MARCH
3/29/00 Van To Patrol Baltimore Streets Offering Free HIV Urine Testing
Johns Hopkins and Sisters Together and Reaching Inc. (STAR) have teamed up to offer Baltimoreans free HIV urine testing from a mobile van. The van will operate five days and evenings per week and patrol areas at high risk for HIV.
3/29/00 Low Blood Levels of HIV Reduce Risk of Heterosexual Transmission
People with HIV infections are less likely to pass the virus to an opposite sex partner if they have low levels of the virus in their blood, according to a new study by researchers from Johns Hopkins, the National Institutes of Health, Makerere University (Kampala, Uganda), the Uganda Virus Research Institute (Entebbe, Uganda), and Columbia University.
3/29/00 High Blood Pressure, Medications Increase Diabetes Risk
People with high blood pressure are two and a half times more likely to develop Type 2, or non-insulin-dependent, diabetes as those with normal blood pressure, according to a study led by researchers at Johns Hopkins and published in the March 30 issue of The New England Journal of Medicine.
3/27/00 Discovery of Brain Phenomenon Could Lead To Better Drugs For Certain Mental Illnesses
Researchers at Johns Hopkins have discovered a phenomenon in the brains of individuals with schizophrenia and other mental illnesses that may help doctors develop better drugs.
3/21/00 Kornfeld, Robert Packard Foundations Fund Innovative Center For ALS Research At Johns Hopkins
The Emily Davie and Joseph S. Kornfeld Foundation of New York and the Robert Packard Foundation have agreed to fund the multimillion dollar Center for ALS Research at The Johns Hopkins University School of Medicine.
3/20/00 CellPro Litigation
3/17/00 Hopkins Researchers Develop A Non-Invasive Screening Test For Cancer
Researchers at Johns Hopkins have developed a novel approach for detecting cancer based on new targets for genetic mutations found outside a cell's nucleus.
3/3/00 Prostate Cancer Test Works as Well for Black Men, Study Shows
A new twist on the standard way to predict prostate cancer risk appears to offer African-American men a much-needed, improved accuracy in detecting the disease.
3/15/00 Hopkins Doctor Uses "Glow Germ" to Teach Cleanliness to Kids and Starts Hand Washing Campaign at Hopkins
When Trish Perl, M.D., an assistant professor of medicine at Johns Hopkins, recently visited two local middle schools, she came armed with a UV light and a bottle of glow germ. Her mission, to emphasize the importance of hand washing, was a shining success, such a success that the kids are helping her launch a hand washing campaign at Hopkins.
3/15/00 Time Important in Transporting Critically Injured to Trauma Centers
In the continuing debate among emergency medical services (EMS) personnel regarding the best pre-hospital management for trauma patients, a new study by Johns Hopkins and the University of Southern California raises the bar on the importance of time.
3/15/00 Scientists Clarify Much-Sought Enzyme, Pave Road To Cancer Therapy
Scientists worldwide have eagerly eyed the enzyme telomerase as an ideal target for anti-cancer therapy. Active in cancer cells, which need it to divide, telomerase has sparked keen research. Biotech companies have pumped millions into finding a telomerase inhibitor.
3/15/00 Study Finds Physicians Err in Treating Tuberculosis, Raising Risk of Drug-resistant Disease
A study by infectious disease experts at Johns Hopkins concludes that public health doctors do a far better job of treating tuberculosis (TB) than private-practice physicians. Results strongly suggest that private doctors are responsible for most of the drug-resistant TB cases emerging in the United States, the study's authors say.
3/10/00 Altering Mechanical Ventilator Patterns Reduces Deaths from Acute Lung Injury and Acute Respiratory Distress Syndrome
Researchers have found that altering the way they use mechanical ventilators to treat patients with acute lung injury and acute respiratory distress syndrome (ALI-ARDS) significantly reduces deaths from the disease. The study, which will be released early on the New England Journal of Medicine Web site on March 10, has profound implications for treating patients with the syndrome, the investigators say.
3/9/00 Hopkins Researcher Receives Presidential Early Career Award
Xiaoqin Wang, Ph.D., Johns Hopkins University assistant professor, has been awarded the coveted Presidential Early Career Award for Scientists and Engineers. The Presidential Awards are intended to recognize young scientists and engineers who "show exceptional potential for leadership at the frontiers of scientific knowledge during the twenty-first century."
3/8/00 Rare But Deadly Heart Disease Is Curable, Study Shows
Fatigue, fever and muscle aches � classic symptoms of flu � are for a small number of patients symptoms of a very rare but deadly form of heart disease. The condition, fulminant myocarditis, is underdiagnosed. The good news, according to a study led by Johns Hopkins researchers, is that patients who are properly diagnosed and treated aggressively can fully recover from the condition within two weeks � without much damage to the heart or chance of relapse.
3/1/00 Study Shows Brain Switch In Men With Schizophrenia
Schizophrenia typically runs a far nastier course in men than in women -- psychiatrists have long known that. The disease tends to strike women later, they are less likely to be totally disabled and their symptoms shade toward more easily treated delusions and hallucinations. They also respond more readily to medication.
FEBRUARY
2/24/00 Carol Johns, Hopkins Lung Specialist, Dies
Carol Johnson Johns, M.D., a world-renowned expert in lung disease, longtime leader at The Johns Hopkins University School of Medicine, and an advocate for women's careers in medicine, died at home Thursday of melanoma. She was 76.
2/21/00 Researchers Face HIV Epidemic at African Americans and AIDS Conference
African-Americans comprise more than 40 percent of all new HIV/AIDS cases, and African-American women make up 60 percent of female cases. These statistics are driving the work of researchers and healthcare workers attending the 2000 National Conference on African-Americans and AIDS at the Renaissance Hotel in Washington, D.C., on February 23-25.
2/19/00 School of Nursing Initiates New Doctoral Program
In response to current cost-conscious trends in the nation's health care system, the Johns Hopkins University School of Nursing is offering a new graduate degree, the Doctor of Nursing Science (DNSc). The only one of its kind in Maryland, the DNSc program focuses on health outcomes measurement, health care economics, statistical analysis, and informatics.
2/18/00 Hopkins Team Verifies First Down Syndrome Mouse
Evidence for a credible animal version of Down syndrome mounted today with a report from Johns Hopkins scientists verifying the syndrome's signature skull and facial deformities in a genetically modified mouse.
2/16/00 Hopkins Reports New Technology To Unmask Hidden Gene Mutations
The Johns Hopkins scientists whose research led to the first blood tests for colon cancer predisposition have now developed a technology that dramatically improves the accuracy of such tests. They can now detect -- nearly 100 percent of the time -- genetic mutations associated with certain hereditary diseases.
2/12/00 Simple Test, MRI Scan May Help Salvage Stroke Patients' Brains
Johns Hopkins scientists report a new way of monitoring brain damage that could significantly increase the number of stroke patients eligible for -- and helped by -- clot-breaking treatments.
2/11/00 Researchers Unlock Secrets of Directional Cell Movement
For years, researchers have puzzled over how some cells guide themselves toward a chemical that spreads itself around. Now, in this week's issue of Science, Johns Hopkins researchers identify a protein that accumulates toward the front end of a cell and helps cells "sense" their way to a target.
2/8/00 Scientists Identify Natural Chemical That Causes Blinding Blood Vessel Growth
A natural chemical substance the eye calls for backup when it's lacking oxygen is responsible for the blinding blood vessel growth that plagues patients with diabetic retinopathy, report researchers at Johns Hopkins and CIBA Vision Corp., a Novartis Ltd. Pharmaceutical Co.
2/4/00 Hopkins School of Medicine First in NIH Funding for FY �99
For the eighth year in a row, The Johns Hopkins University School of Medicine is the nation's top earner of federal biomedical research funding. According to figures just released by the National Institutes of Health (NIH) for fiscal year 1999, Hopkins scientists were awarded more than $255 million in competitive grants. Most of that (around $227 million or 89 percent) went directly to support basic or clinical research.
2/3/00 Hopkins Researchers Identify Neurologic Problem Associated with Motor Disorders in Huntington's Disease
For more than a century, tremors and jerky movements have been recognized as the hallmarks of Huntington's disease (HD). Scientists have long known these motor control disturbances result from damaged brain cells. Now, researchers at Johns Hopkins think they may have identified the nervous system mechanism linked to these symptoms and the part of the brain causing them. They also found that subtle jerkiness in movements may appear in HD patients long before clinical symptoms of the disease are first seen, perhaps providing physicians with a new diagnostic tool for early HD.
2/2/00 Hopkins Experts Named Team Physicians for BayRunners.
Johns Hopkins Medical Institutions has been selected to provide all medical care for Baltimore's new professional basketball team, the BayRunners. The effort is being coordinated by Hopkins' Division of Sports Medicine and Shoulder Surgery, headed by orthopedic surgeon Edward G. McFarland, M.D.
2/1/00 The Silent Time Bomb: Divorce, Health Care And The Baby Boom Generation
Baby boomers now approaching the Medicare years may be bringing a time bomb with them. Half of them have been divorced, and researchers at Johns Hopkins have found that elderly people with divorce in their lives will get less care from their children than people who do not. They are even less likely to get help from their stepchildren.
JANUARY
1/31/00 Salmonella's Molecular Mimics May Spark Arthritis
Scientists at Johns Hopkins have uncovered an important link between getting specific bacterial infections and developing autoimmune diseases such as arthritis.
1/30/00 Drug that Cuts Rate of Mother-to-Child Transmission of HIV Given Top Honors
The identification of a simple, affordable drug regimen that is highly effective in preventing mother-to-child transmission of HIV has been named the ninth greatest health advance of 1999 by CNN. The drug, nevirapine, was identified through a collaborative effort between researchers at The Johns Hopkins University School of Medicine and Makerere University in Kampala, Uganda.
1/28/00 Kate O'Rourke Joins Hopkins Public Affairs Office
Kate O'Rourke, a science journalist who has written for local and national publications, has joined the Office of Communications and Public Affairs at Johns Hopkins Medical Institutions as a senior media relations representative.
1/26/00 Mortician Becomes Infected With TB From Cadaver
Johns Hopkins researchers have reported the first known case of tuberculosis (TB) transmitted from a cadaver to an embalmer, according to a case study in the Jan. 27 issue of the New England Journal of Medicine.
1/20/00 "Stunning" Discovery Finds Cause of Heart Failure After Surgery
Scientists at Johns Hopkins and Queen's University in Ontario have shown that a small molecular glitch is responsible for the sudden heart failure that almost universally strikes after open heart surgery and that costs this country an estimated $10 billion in post-operative medical care every year.
1/20/00 Routine Preoperative Tests For Cataract Surgery Are Unnecessary
Standard medical tests routinely performed before cataract surgery do not measurably improve outcomes or reduce deaths or complications from the surgery, according to a Johns Hopkins-led study.
1/11/00 Whipple Patients Report Good Quality of Life After Surgery
Contrary to widespread belief among doctors and patients, patients who get through a major operation that removes the head of the pancreas, part of the small intestine and part of the bile ducts report a surprisingly high quality of life, a Johns Hopkins study shows.
1/10/00 Hopkins, GW Joint Venture to Provide Kidney Disease Services in Mid-Atlantic Region
Johns Hopkins Medicine (JHM) and George Washington University (GW) have teamed up to form a new company to streamline and enhance dialysis and other kinds of care for patients living in the Mid-Atlantic region and suffering from end stage renal disease (ESRD) and other kidney conditions.
1/5/00 Side Effects of Prostate Cancer Surgery Far less When Performed by Specialist
Many men with prostate cancer may endanger their lives by avoiding prostate removal, unwilling to deal with the surgery's reported side effects. Now, in a study reported in the January issue of Urology, Johns Hopkins researchers conclude that when patients seek out a surgeon highly experienced in the procedure, they are far more likely to remain continent and potent than if their operations were done by a less experienced doctor.
1/5/00 Video Review Comes to the Operating Room: Videotaping Surgeries Offers Opportunities to Improve Outcomes
Many athletes, including golfers and baseball and football players, videotape and review games to improve their performances. Now, in a study reported in the January issue of Urology, Johns Hopkins researchers conclude that videotaping also can help doctors improve the outcome of prostate surgeries and possibly others.
1/4/00 Researchers Identify Liver Toxicity Risk of Aids Drugs: Ritonavir Worst Offender
Ten percent of HIV-infected individuals taking antiretroviral drugs experience liver toxicity at a level high enough to warrant stopping treatment, according to new findings by Johns Hopkins researchers. Results of the study in the Jan. 5 issue of the Journal of the American Medical Association, also showed that liver toxicity was five times higher with taking one particular protease inhibitor, ritonavir, which accounted for half of all cases in the study.

-- JHMI --
Search Press Releases

-----------------------------------------
News Media Home | Hopkins Medicine Home

 

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

U.S. 1-410-464-6713 (toll free)
International +1-410-614-6424

 

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer